
Join to view full profile
988102 Nebraska Medical CtrOmaha, NE 68198
Phone+1 402-559-9800
Fax+1 402-559-4835
Dr. Armitage is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Iowa Health Care Medical CenterFellowship, Hematology and Medical Oncology, 1976 - 1977
University of Iowa Health Care Medical CenterResidency, Internal Medicine, 1975 - 1976
University of Nebraska Medical Center College of MedicineResidency, Internal Medicine, 1973 - 1975
University of Nebraska College of MedicineClass of 1973
Certifications & Licensure
NE State Medical License 1973 - 2028
IA State Medical License 1975 - 2000
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2013-2014, 2016-2017
Publications & Presentations
PubMed
- Consolidative radiation in the management of relapsed/refractory Hodgkin lymphoma: a single institution study.Brendan Coutu, Joseph Carmicheal, Elliot Lawrence, Ashok Bhandari, Robert G Bociek
Radiation Oncology. 2026-05-27 - 5 citationsAcademic and community cancer center collaboration in acute myeloid leukemia: a road map to optimize care delivery.Prajwal Dhakal, James O Armitage, Vijaya Raj Bhatt
Leukemia & Lymphoma. 2025-08-01 - 9 citationsA Phase II Trial of Geriatric Assessment-Guided Selection of Treatment Intensity in Older Adults With AML.Vijaya R Bhatt, Christopher S Wichman, Thuy T Koll, Alfred L Fisher, Tanya M Wildes
American Journal of Hematology. 2025-07-01
Journal Articles
- Do You Know TAFRO?James O Armitage, Matthew A Lunning, Blood
Abstracts/Posters
- The Effect of Age and CD34+ Stem Cell Dose on Autologous Hematopoietic Stem Cell Transplantation Outcomes in Multiple Myeloma _ Single Institution ExperienceJames O. Armitage, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Integrating Geriatric Assessment and Genetic Profiling to Personalize Therapy Selection in Older Adults with Acute Myeloid Leukemia (AML)James O. Armitage, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Effect of Using Multiagent Versus Single Agent Chemotherapy on Overall Survival (OS) of Older Adults with Acute Myeloid Leukemia (AML)James O. Armitage, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
Recent Advances in Treating Diffuse Large B-Cell LymphomaMay 20th, 2025
Nivolumab Appears to Boost Cure Rate in Advanced Hodgkin LymphomaNovember 14th, 2024
Nivolumab Regimen Achieves Durable PFS in Advanced Hodgkin's LymphomaOctober 16th, 2024
Committees
- Co-chair, 2015 Update Committee, American Society of Clinical Oncology (ASCO) 2015 - Present
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: